Total investments 13
Average round size 
$36M
The average size of a deal this fund participated in
Portfolio companies 8
Rounds per year 2.17
Lead investments 0
Follow on index
0.38How often the fund supports its portfolio startups at next rounds
Key employees Soon
Oberhaching, Bavaria, Germany Related Funds
Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of 415 CAPITAL Management:
Typical Co-investors
415 CAPITAL Management is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after 415 CAPITAL Management:
There are no funds here. If we find new data, we will add it here.
Look at other 50 related and similar funds Collapse list ↓
| Fund Name | Location |
| East Africa Capital Partners | Kenya, Nairobi, Nairobi Area |
| Fullscreen | California, Culver City, United States |
| Generation Growth Capital | Chicago, Illinois, United States |
| Guoqian Venture Capital | China, Haimen, Jiangsu |
| Heyihui Capital | Beijing, Beijing, China |
| Kiraboshi Bank | Chiyoda, Japan |
| Lianchuang Yongxuan Investment | China, Shanghai |
| MedCity News | Cleveland, Ohio, United States |
| Oman Technology Fund | Masqat, Muscat, Oman |
| Portuguese venture capital groups | Brazil, Rio Grande do Sul, Viamão |
| Proman | - |
| Seed Capital Partners | Dallas, Texas, United States |
| SEEDRA | Ar Riyad, Riyadh, Saudi Arabia |
| SEQ Capital Partners | Dubai, United Arab Emirates |
| Startupxplore | Spain, Valencia, Valencian Community |
| Swedbank | Lithuania, Vilniaus Apskritis, Vilnius |
| Woodline Partners | California, San Francisco, United States |
| Zedcrest Capital Limited | Lagos, Lagos, Nigeria |
| Zhongcai Xingye Touzi | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
CorFlow Therapeutics AG | $51M | 10 Sep 2024 | Zug, Switzerland | ||
R3 Vascular Inc. | $87M | 09 May 2024 | - | ||
Aktiia | $29M | 27 Feb 2024 | Neuchâtel, Switzerland | ||
Tricares | $55M | 16 Sep 2022 | Paris, Ile-de-France, France | ||
Supira Medical | $30M | 28 Feb 2022 | California, United States | ||
Aktiia | $17M | 02 Nov 2021 | Neuchâtel, Switzerland | ||
Cardiac Success | $5M | 24 Jun 2021 | Nazareth Illit, HaZafon, Israel | ||
| $5M | 12 Apr 2021 | Mountain View, California, United States | |||
CorFlow Therapeutics AG | $8M | 01 Mar 2021 | Zug, Switzerland |
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
To post a comment or write a complain, please sign in with LinkedIn
Review
- No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Do you represent 415 CAPITAL Management?
Get access to manage this page
Found incorrect info? Let us know!
Total investments 13
Average round size 36M
Rounds per year 2.17
Peak activity year 2021
Lead investments 0
Follow on index 0.38
Group Appearance index 0.77
Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
CorFlow Therapeutics AG | $51M | 10 Sep 2024 | Zug, Switzerland | ||
R3 Vascular Inc. | $87M | 09 May 2024 | - | ||
Aktiia | $29M | 27 Feb 2024 | Neuchâtel, Switzerland | ||
Tricares | $55M | 16 Sep 2022 | Paris, Ile-de-France, France | ||
Supira Medical | $30M | 28 Feb 2022 | California, United States | ||
Aktiia | $17M | 02 Nov 2021 | Neuchâtel, Switzerland | ||
Cardiac Success | $5M | 24 Jun 2021 | Nazareth Illit, HaZafon, Israel | ||
| $5M | 12 Apr 2021 | Mountain View, California, United States | |||
CorFlow Therapeutics AG | $8M | 01 Mar 2021 | Zug, Switzerland |
